Gilead Sciences (Call) (GILD) Share Price Declined While Ardsley Advisory Partners Trimmed Its Holding; As Cintas (CTAS) Shares Rose, Buckingham Asset Management Has Increased Its Holding by $315,360

January 18, 2018 - By Marguerite Chambers

Buckingham Asset Management Llc increased its stake in Cintas Corp (CTAS) by 61.88% based on its latest 2017Q3 regulatory filing with the SEC. Buckingham Asset Management Llc bought 2,190 shares as the company’s stock rose 2.03% with the market. The institutional investor held 5,729 shares of the apparel company at the end of 2017Q3, valued at $827,000, up from 3,539 at the end of the previous reported quarter. Buckingham Asset Management Llc who had been investing in Cintas Corp for a number of months, seems to be bullish on the $17.24 billion market cap company. The stock decreased 0.46% or $0.745 during the last trading session, reaching $161.925. About 125,979 shares traded. Cintas Corporation (NASDAQ:CTAS) has risen 32.38% since January 18, 2017 and is uptrending. It has outperformed by 15.68% the S&P500.

Philip Hempleman decreased its stake in Gilead Sciences Inc (Call) (GILD) by 66.67% based on its latest 2017Q3 regulatory filing with the SEC. Ardsley Advisory Partners sold 50,000 shares as the company’s stock declined 8.05% while stock markets rallied. The hedge fund run by Philip Hempleman held 25,000 shares of the health care company at the end of 2017Q3, valued at $2.03 million, down from 75,000 at the end of the previous reported quarter. Ardsley Advisory Partners who had been investing in Gilead Sciences Inc (Call) for a number of months, seems to be less bullish one the $105.97B market cap company. The stock decreased 0.76% or $0.62 during the last trading session, reaching $81.12. About 2.27 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since January 18, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Ardsley Advisory Partners, which manages about $862.45 million and $751.91M US Long portfolio, upped its stake in Expedia Inc Del (NASDAQ:EXPE) by 41,500 shares to 46,500 shares, valued at $6.69 million in 2017Q3, according to the filing. It also increased its holding in Canadian Solar Inc (NASDAQ:CSIQ) by 200,500 shares in the quarter, for a total of 300,500 shares, and has risen its stake in First Solar Inc (Put) (NASDAQ:FSLR).

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 19 have Buy rating, 0 Sell and 11 Hold. Therefore 63% are positive. Gilead Sciences had 112 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by BMO Capital Markets on Friday, July 21. Vetr upgraded it to “Buy” rating and $129.16 target in Monday, August 17 report. William Blair maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Wednesday, June 14 with “Buy” rating. The firm earned “Hold” rating on Monday, August 28 by BMO Capital Markets. The firm has “Outperform” rating by Oppenheimer given on Wednesday, July 29. The rating was initiated by Berenberg with “Buy” on Thursday, September 22. The rating was maintained by Cowen & Co on Monday, September 21 with “Buy”. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Jefferies on Wednesday, August 31. On Friday, February 5 the stock rating was initiated by Leerink Swann with “Outperform”. The firm has “Outperform” rating by Wells Fargo given on Tuesday, January 16.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on February, 6. They expect $1.67 EPS, down 36.74% or $0.97 from last year’s $2.64 per share. GILD’s profit will be $2.18B for 12.14 P/E if the $1.67 EPS becomes a reality. After $2.23 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -25.11% negative EPS growth.

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.10, from 0.93 in 2017Q2. It improved, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Opus Point Partners Management Lc owns 6,462 shares. Rhumbline Advisers has invested 0.41% in Gilead Sciences, Inc. (NASDAQ:GILD). Virtus Advisers invested 0.04% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). 4,660 are held by Baxter Bros. Holt Capital Advsrs Lc Dba Holt Capital Partners LP holds 7,680 shares. Hartford Inv Mngmt Com has invested 0.45% in Gilead Sciences, Inc. (NASDAQ:GILD). 116,296 were accumulated by Rock Point Advsr Ltd Com. Parnassus Ca accumulated 6.21% or 18.70M shares. Advisory Rech holds 2,741 shares or 0% of its portfolio. Point72 Asia (Hong Kong) Ltd holds 0.17% in Gilead Sciences, Inc. (NASDAQ:GILD) or 2,981 shares. Kessler Ltd Liability Corporation owns 13,079 shares. First Tru Communications holds 16,665 shares or 0.16% of its portfolio. Raymond James Na, a Florida-based fund reported 26,391 shares. Ny State Teachers Retirement Sys holds 0.46% or 2.29M shares in its portfolio. Markel Corporation holds 33,000 shares or 0.05% of its portfolio.

Since August 1, 2017, it had 0 insider purchases, and 12 selling transactions for $43.50 million activity. 51,820 Gilead Sciences, Inc. (NASDAQ:GILD) shares with value of $4.40M were sold by Washington Robin L. Another trade for 73,333 shares valued at $6.09 million was made by MARTIN JOHN C on Thursday, August 31. $4.99M worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by Meyers James R on Thursday, August 31.

Investors sentiment decreased to 1.02 in 2017 Q3. Its down 0.02, from 1.04 in 2017Q2. It is negative, as 37 investors sold CTAS shares while 174 reduced holdings. 80 funds opened positions while 135 raised stakes. 69.32 million shares or 1.23% more from 68.47 million shares in 2017Q2 were reported. The Connecticut-based Paloma Prtnrs Mgmt Company has invested 0.02% in Cintas Corporation (NASDAQ:CTAS). Cleararc Capital Inc invested in 0.05% or 2,458 shares. Bnp Paribas Asset Mgmt owns 0.01% invested in Cintas Corporation (NASDAQ:CTAS) for 10,984 shares. Liberty Mutual Gp Asset holds 0.03% in Cintas Corporation (NASDAQ:CTAS) or 3,691 shares. Farmers And Merchants owns 52 shares. Arrowstreet Capital Partnership reported 0.01% of its portfolio in Cintas Corporation (NASDAQ:CTAS). Moreover, Old Mutual Customised Solutions (Proprietary) has 0.04% invested in Cintas Corporation (NASDAQ:CTAS) for 1,800 shares. University Of Notre Dame Du Lac owns 1.44% invested in Cintas Corporation (NASDAQ:CTAS) for 35,783 shares. Utah Retirement Systems stated it has 15,664 shares or 0.05% of all its holdings. Huntington Natl Bank invested 0.01% of its portfolio in Cintas Corporation (NASDAQ:CTAS). Lpl Fin Ltd Liability Corporation owns 29,912 shares. Fmr Ltd Llc owns 2.05M shares for 0.04% of their portfolio. Dupont Capital Mngmt Corporation holds 55,222 shares or 0.18% of its portfolio. Rafferty Asset Mngmt Ltd Liability has 0.04% invested in Cintas Corporation (NASDAQ:CTAS) for 11,654 shares. Next Fin Group Inc has 0.01% invested in Cintas Corporation (NASDAQ:CTAS) for 180 shares.

Since August 11, 2017, it had 0 insider purchases, and 3 insider sales for $2.37 million activity. 2,000 Cintas Corporation (NASDAQ:CTAS) shares with value of $267,380 were sold by Adolph Gerald S. Shares for $1.99 million were sold by Holloman James Phillip.

Among 15 analysts covering Cintas (NASDAQ:CTAS), 5 have Buy rating, 2 Sell and 8 Hold. Therefore 33% are positive. Cintas had 40 analyst reports since August 14, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, September 21 by KeyBanc Capital Markets. The company was maintained on Wednesday, September 27 by Morgan Stanley. The rating was maintained by Morgan Stanley on Tuesday, July 25 with “Underweight”. The company was upgraded on Wednesday, April 13 by KeyBanc Capital Markets. The stock has “Neutral” rating by Instinet on Tuesday, June 27. The firm earned “Buy” rating on Thursday, September 28 by Robert W. Baird. Barclays Capital upgraded it to “Overweight” rating and $130 target in Wednesday, August 17 report. Stifel Nicolaus maintained Cintas Corporation (NASDAQ:CTAS) rating on Tuesday, September 26. Stifel Nicolaus has “Hold” rating and $138.0 target. RBC Capital Markets maintained the stock with “Hold” rating in Thursday, September 28 report. Barclays Capital maintained the shares of CTAS in report on Wednesday, September 27 with “Overweight” rating.

Buckingham Asset Management Llc, which manages about $6.11 billion and $420.44M US Long portfolio, decreased its stake in Vanguard Bd Index Fd Inc (BND) by 3,777 shares to 15,682 shares, valued at $1.29 million in 2017Q3, according to the filing. It also reduced its holding in Vanguard Intl Equity Index F (VEU) by 24,205 shares in the quarter, leaving it with 17,247 shares, and cut its stake in Vanguard Index Fds (VTI).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: